EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)

Friday 13 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom